RYE, N.Y., Nov. 18, 2014 /PRNewswire/ -- Curemark, a leading drug research and development company focused on the treatment of neurological and other diseases, is proud to announce that Dr. Joan Fallon, CEO and founder, was honored at The 2014 Stevies Award for Women in Business ceremony and presented with the Gold Maverick of the Year Award. The Stevies Award Ceremony honors executives and entrepreneurs who exemplify visionary business leadership and whose work results in broad benefit to humanitarian or charitable causes around the world. Dr. Fallon was recognized for her commitment to realizing her dream of developing a treatment that could help millions of children with autism. The award ceremony took place on Friday November 14, at the Marriott Marquis in New York, NY.
"Dr. Fallon's motivation to challenge convention and her determination to help others has resulted in a promising new hope for many children with autism who currently have no treatment options that address the core and non-core symptoms of their disorder," said Michael Gallagher, founder and president of the Stevie Awards. "The implications of her research have the potential to profoundly improve the lives of the many children and their families who live with the challenges of autism."
Dr. Fallon founded Curemark based on her observations on the critical role that pancreatic secretory deficiencies play in the etiology of neurological diseases. Through her leadership, Curemark is advancing its lead product CM-AT, a potential first-in-class treatment for autism and the first therapy to address the core symptoms of the disease, successfully through late-stage clinical trials.
"On behalf of the whole team at Curemark, I want to thank the Stevie Awards for recognizing the work we are doing to advance the treatment of autism, a condition that affects millions of families in the U.S. and across the globe," said Dr. Fallon. "We are particularly honored to be recognized as Maverick of the Year because disruptive thinking is at the heart of both our scientific research and our business strategy."
For more coverage on The Stevies Awards Ceremony, visit http://www.stevieawards.com/pubs/women/awards/414_2252_24991.cfm.
About The Stevie® Awards
The Stevie Awards were created in 2002 to honor and generate public recognition of the achievements and positive contributions of organizations and working professionals worldwide. Since then, they have become one of the world's most coveted prizes, and considered one of the world's premier business awards. There are several awards programs, each with its own focus, list of categories, and schedule. The Stevie Awards for Women in Business are open to all organizations worldwide, and recognize the achievements of women executives, entrepreneurs, and the organizations they run.
Stevie Award judges include many of the world's top executives, entrepreneurs, innovators, and business educators. Each awards program harnesses the insights and talents of more than 200 judges every year. Sponsors of Stevie Awards programs include many leading B2B marketers, publishers, and government institutions.
Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company previously announced that its Phase III double blind randomized placebo controlled multicenter clinical trial of CM-AT for autism met its primary and secondary endpoints. To learn more about our innovative science, visit www.curemark.com
Chantal Beaudry, Managing Director
Email: [email protected]